{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T21:56:36Z","timestamp":1726437396191},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>Abstracts<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Beh\u00e7et\u2019s disease (BD) is a chronic multisystem inflammatory disorder characterized by vasculitis. Vasculitis is thought to underlie many of the clinical manifestations of Beh\u00e7et\u2019s disease. Lipoprotein\u2010associated phospholipase A<jats:sub>2<\/jats:sub> (Lp\u2010PLA<jats:sub>2<\/jats:sub>) is a highly specific biomarker for vascular inflammation, and has low biological variability. Those features make it more attractive than other inflammatory markers including C\u2010reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which may reflect systemic inflammation non\u2010specifically.<\/jats:p><jats:p><jats:bold>Objectives\u2002<\/jats:bold> It was aimed to investigate circulating Lp\u2010PLA<jats:sub>2<\/jats:sub> levels and its relationship with CRP and ESR in patients with BD by considering disease activity.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Study group included 72 patients with BD (34 men and 38 women with a mean age of 35.3\u2003years) and 30 sex\u2010 and age\u2010matched healthy subjects (15 men and 15 women with a mean age 32.6\u2003years). Patients group included 40 patients with active and 32 patients with inactive BD.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Lp\u2010PLA<jats:sub>2<\/jats:sub>, CRP and ESR levels were found to be significantly higher in patient group than controls. In addition, those levels were also significantly higher in patients with active BD than in patients with inactive disease. Lp\u2010PLA<jats:sub>2<\/jats:sub> showed positive correlations with CRP and ESR (<jats:italic>r<\/jats:italic>\u2003=\u20030.63, <jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05 and <jats:italic>r<\/jats:italic>\u2003=\u20030.33, <jats:italic>P\u2003<\/jats:italic>&lt;\u20030.05 respectively). Lp\u2010PLA<jats:sub>2<\/jats:sub> also showed significant important area under curve (AUC) value (0.779), besides CRP (0.941) and ESR (0.888). Optimum cut\u2010off value was obtained as 218.5\u2003ng\/mL.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> It was concluded that Lp\u2010PLA<jats:sub>2<\/jats:sub> may be a new useful biomarker to evaluate clinical or subclinical activity of the disease besides CRP and ESR.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2012.04631.x","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T10:05:34Z","timestamp":1341309934000},"source":"Crossref","is-referenced-by-count":4,"title":["Lipoprotein\u2010associated phospholipase A<sub>2<\/sub> level in patients with Beh\u00e7et\u2019s disease"],"prefix":"10.1111","volume":"27","author":[{"given":"A.","family":"\u00d6rem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yayli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Ar\u0131ca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Akcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.B.","family":"Y\u00fccesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bahadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-010-0132-z"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-857X(21)01067-X","article-title":"Vasculitis in Beh\u00e7et\u2019s disease","volume":"16","author":"O\u2019Duffy JD","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8064-8"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(00)00105-0"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3380479"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2009.01.004"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318921"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1986.tb02232.x"},{"key":"e_1_2_5_10_2","first-page":"1078","article-title":"International Study Group for Beh\u00e7et\u2019s Disease","volume":"335","author":"Criteria for diagnosis of Beh\u00e7et\u2019s disease","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"e_1_2_5_11_2","first-page":"309","article-title":"Biological variability and specificity of lipoprotein\u2010associated phospholipase A2 (Lp\u2010PLA), a novel marker of cardiovascular risk","volume":"110","author":"Wolfert RL","year":"2004","journal-title":"Circulation"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00477.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890701204866"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(02)00290-4"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.9.726"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(97)00613-0"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018122"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200301000-00006"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0098-8"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.2006.2.2.153"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8175.2010.01180.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.612630"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032804"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200501000-00006"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"11F","DOI":"10.1016\/j.amjcard.2008.04.014","article-title":"Lipoprotein\u2010associated phospholipase A2: a risk marker or a risk factor","volume":"101","author":"Lerman A","year":"2008","journal-title":"Am J Cardiol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2012.04631.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2012.04631.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T04:14:01Z","timestamp":1697343241000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2012.04631.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1111\/j.1468-3083.2012.04631.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04631.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"type":"print","value":"0926-9959"},{"type":"electronic","value":"1468-3083"}],"subject":[],"published":{"date-parts":[[2012,7,3]]}}}